: /{rthroCare
APR 1 6 2003
KO3Z0954
ee
510(k) Summary
ArthroCare Corporation
ArthroCare® PercD™ SpineWand™

General Information
Submitter Name/Address: ArthroCare Corporation

680 Vaqueros Avenue

Sunnyvale, CA 94085-2936
Establishment Registration Number: 2951580
Contact Person: Valerie Defiesta-Ng

Director, Regulatory Affairs
Date Prepared: March 25, 2003
Device Description
Trade Name: ArthroCare® PercD™ SpineWand™
Generic/Common Name: Electrosurgical Device and Accessories
Classification Name: Electrosurgical Cutting and Coagulation

Device and Accessories (21 CFR

878.4400)
Predicate Devices
ArthroCare PercD SpineWand K020621
Product Description
The Wands are bipolar, single use, high frequency electrosurgical devices.
Intended Use
The Perc-D™ SpineWand™ is indicated for ablation, coagulation, and decompression. of
disc material to treat symptomatic patients with contained herniated discs.

680 Vaqueros Avenue * Sunnyvale, CA 94085 ° (408) 736-0224 © Fax: (408) 736-0226 :
ix

Substantial Equivalence
This Special 510(k) proposes modifications in dimensional specifications, materials, and
labeling for the ArthroCare PercD SpineWand, which were previously cleared under
K020621 on March 28, 2002. The indications for use, technology, principle of operation,
performance specifications, packaging, or sterilization parameters of the Spine Wands
remain the same as in the predicate cleared 510(k).
Summary of Safety and Effectiveness
The modified SpineWands, as described in this submission, are substantially equivalent
to the predicate SpineWands. The proposed modification in dimensional specifications,
materials, and labeling are not substantial changes or modifications, and do not
significantly affect the safety or efficacy of the devices.

x

co
: a DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
ng i
wera Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
APR 1 6 2003

Ms. Valerie Defiesta-Ng
Direttor, Regulatory Affairs
ArthroCare Corporation
680 Vaqueros Avenue
Sunnyvale, California 94085-2936
Re: K030954 :

Trade/Device Name: ArthroCare® PercD™ SpineWand™

Regulation Number: 21 CFR 878.4400

Regulation Names: Electrosurgical cutting and coagulation device and accessories

Regulatory Class: II

Product Codes: GEI

Dated: March 26, 2003

Received: March 27, 2003
Dear Ms. Defiesta-Ng:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, gooa manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with al] the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Valerie Defiesta-Ng
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the
promotion and advertising of your device, please contact the Office of Compliance at (301) 5944639. Also, please note the regulation entitled, "Misbranding by reference to premarket
notification” (21CFR Part 807.97) you may obtain. Other general information on your
responsibilities under the Act may be obtained from the Division of Small Manufacturers,
International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597
or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Meuey C Vrovet
foCelia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

Indications for Use Statement
Device Name: ArthroCare® Perc-D™ SpineWand™
510(k) Number: K 030954 .
Indications for use: .
The Pere-D™ SpineWand”™ is indicated for ablation, coagulation, and decompression of
disc material to treat symptomatic patients with contained herniated discs.
Merona C9 neve
(Division Sign-Off)
Division of General, Restorative
and Neurologicai ievices
510(k) Number O30 75°
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) ,
Prescription Use x OR Over-the-Counter
Use
(Per 21 CFR
801.109)
viii

